Thiogenesis Therapeutics, Corp. (TSXV:TTI)
0.8000
-0.0200 (-2.44%)
Jul 24, 2025, 4:00 PM EDT
Thiogenesis Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence. Standard template. Financial Sources.